CLOV vs. SKLZ, ALHC, LUNG, ACB, DCGO, AURA, TNYA, TERN, NATR, and MODV
Should you be buying Clover Health Investments stock or one of its competitors? The main competitors of Clover Health Investments include Skillz (SKLZ), Alignment Healthcare (ALHC), Pulmonx (LUNG), Aurora Cannabis (ACB), DocGo (DCGO), Aura Biosciences (AURA), Tenaya Therapeutics (TNYA), Terns Pharmaceuticals (TERN), Nature's Sunshine Products (NATR), and ModivCare (MODV).
Skillz (NYSE:SKLZ) and Clover Health Investments (NASDAQ:CLOV) are both small-cap consumer discretionary companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, community ranking, analyst recommendations and valuation.
In the previous week, Skillz had 2 more articles in the media than Clover Health Investments. MarketBeat recorded 3 mentions for Skillz and 1 mentions for Clover Health Investments. Skillz's average media sentiment score of 0.73 beat Clover Health Investments' score of -0.42 indicating that Clover Health Investments is being referred to more favorably in the news media.
Clover Health Investments has a net margin of -8.63% compared to Clover Health Investments' net margin of -78.69%. Skillz's return on equity of -48.07% beat Clover Health Investments' return on equity.
Skillz presently has a consensus price target of $11.50, suggesting a potential upside of 80.53%. Clover Health Investments has a consensus price target of $1.50, suggesting a potential upside of 68.54%. Given Clover Health Investments' stronger consensus rating and higher probable upside, equities analysts clearly believe Skillz is more favorable than Clover Health Investments.
19.4% of Skillz shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 22.7% of Skillz shares are owned by company insiders. Comparatively, 21.8% of Clover Health Investments shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Skillz has higher earnings, but lower revenue than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Skillz, indicating that it is currently the more affordable of the two stocks.
Skillz has a beta of 2.76, suggesting that its share price is 176% more volatile than the S&P 500. Comparatively, Clover Health Investments has a beta of 1.88, suggesting that its share price is 88% more volatile than the S&P 500.
Skillz received 15 more outperform votes than Clover Health Investments when rated by MarketBeat users. Likewise, 55.38% of users gave Skillz an outperform vote while only 39.62% of users gave Clover Health Investments an outperform vote.
Summary
Skillz beats Clover Health Investments on 11 of the 18 factors compared between the two stocks.
Get Clover Health Investments News Delivered to You Automatically
Sign up to receive the latest news and ratings for CLOV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CLOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Clover Health Investments Competitors List
Related Companies and Tools
